2020 ASCO Virtual Direct™ Highlights

 

2020 ASCO Virtual Direct™ Highlights
L

2020 ASCO Highlights on Aggressive B-Cell Lymphomas: Can Venetoclax Work as Initial Therapy? Is AUTO3 CAR-T Agent Promising in DLBCL?

By 2020 ASCO Virtual Direct™ Highlights FEATURING Luis Fayad
By 2020 ASCO Virtual Direct™ Highlights FEATURING Luis Fayad
40 views
October 12, 2020
0 Comments
Login to view comments. Click here to Login

Featured Video

24:44
Indy Hematology Review

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Feat. R. Birhiray

Featured Video

20:25
Exelixis

Primary Analysis and Follow-up Data of a Combination Therapy in 1L a…

Feat. S. Ratnam
Hematologic Oncology
05:34
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Updates on Relapsed DLBCL: Is Auto-HCT Beneficial in PET/C…

Feat. L. Fayad
07:11
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Updates on R/R iNHL: Does Axi-Cel Combination Offer Promis…

Feat. L. Fayad
05:18
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Highlights on Previously Untreated CLL: Does Time-Limited …

Feat. L. Fayad
06:14
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Updates on R/R cHL: Does Pembro Show Any PFS Improvement C…

Feat. L. Fayad
06:09
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Highlights on Aggressive B-Cell Lymphomas: Can Venetoclax …

Feat. L. Fayad